Filter
58
Filtered Results: 58
Text search:
Inserm
Featured
Recommendations
3
New Publications
11
Language
Document type
No document type
31
Studies & Reports
12
Guidelines
9
Manuals
3
Videos
1
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
Burkina Faso
3
Guinea
2
Liberia
2
Brazil
2
Global
2
Sierra Leone
1
Guinea-Bissau
1
Cameroon
1
South Africa
1
Bangladesh
1
Mozambique
1
Ukraine
1
Angola
1
Madagascar
1
Latin America and the Carribbean
1
Western and Central Europe
1
Africa
1
North America
1
Authors & Publishers
Publication Years
Category
Public Health
6
Countries
6
Clinical Guidelines
6
Women & Child Health
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
HIV
20
COVID-19
8
Ebola
7
Mental Health
4
TB
3
Disability
2
Rapid Response
2
Caregiver
2
Planetary Health
2
AMR
1
NTDs
1
NCDs
1
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
Recommandations formalisées d'experts
To provide a foundation for the strategic policy and programme development needed to ensure the sustainable implementation of effective interventions for reducing the global burden of PPH
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Recommendations for a public health approach
2010 revision
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Recommandations pour une Approche de Santé publique.
Juin 2013.
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
BMC Public Health, Volume 18, Article number: 303 (2018)
https://doi.org/10.1186/s12889-018-5208-0
Published: 02 March 2018
